News

Viridien Welcomes Amélie Oyarzabal to the Board Following Changes

Viridien Welcomes Amélie Oyarzabal to the Board Following Changes

Viridien Announces Board Changes with New Appointments

Viridien has made significant changes to its Board of Directors that signal a strategic shift within the company. With the resignation of Helen LEE BOUYGUES, the company has also welcomed Amélie OYARZABAL as the new independent Director. This move is not just a routine update; it reflects the company’s commitment to enhancing its leadership team with experienced professionals who can drive Viridien forward.

Departure of Helen Lee Bouygues

Helen LEE BOUYGUES has decided to step down from her role as a Director. Her resignation was effective as of September 11, 2024, allowing her to focus on other responsibilities. Since joining Viridien in 2018, Helen has played a pivotal role in guiding the company through significant transformation. Her insight and expertise have greatly influenced the strategic direction of the Group.

Accomplishments of Helen Lee Bouygues

During her tenure, Helen has been instrumental in shaping many critical initiatives, contributing to both the organizational and financial growth of Viridien. The Board expresses gratitude for her invaluable contributions, which have been essential in navigating the complexities of the evolving business landscape.

Welcome Amélie Oyarzabal to the Board

In a move characterized by foresight and strategic planning, the Board co-opted Amélie OYARZABAL to take over the responsibilities left by Helen. This appointment follows the recommendations of the Appointment, Remuneration, and Governance Committee, showcasing Viridien’s commitment to ensuring a seamless transition in its leadership.

Amélie Oyarzabal’s Background

Amélie brings over 25 years of financial advisory experience to the table. A graduate of Sciences Po, Paris, and the London School of Economics, she has held prestigious positions, including Partner at Lazard Frères. Notably, she played a crucial role in launching Lazard’s Beijing office and later in Chicago. In 2019, she joined Greenhill & Co., Inc. as Managing Director, where she is responsible for spearheading the French office.

Strategic Roles and Committees

As an independent Director, Amélie will serve not only on the Board but also as a member of both the Audit & Risk Management Committee and the New Businesses and M&A Committee. Amid these changes, Sophie ZURQUIYAH, CEO and Director, will act as the interim Chairman of the New Businesses and M&A Committee until a permanent successor is appointed, ensuring continuity in leadership.

Quotes from the Chairman of the Board

Philippe SALLE, Chairman of the Board of Directors, stated, “We are delighted to welcome Amélie OYARZABAL to the Board of Directors of Viridien. Her extensive experience and accomplishments in finance will be highly valuable to our Company.” His sentiments echo the positive outlook that the Board has for the future, aiming for sustained growth and innovation.

About Viridien

Viridien is a forward-thinking digital and Earth data company dedicated to driving scientific advancements and sustainable solutions. With around 3,500 employees globally, the company strives to discover new insights and technologies that address complex challenges associated with natural resources, energy transitions, and infrastructure development. Viridien is traded on the Euronext Paris SA under the ticker VIRI.

Contact Information

For inquiries, please reach out to the Legal Department at 27 avenue Carnot, 91300 Massy.

Frequently Asked Questions

Who has resigned from the Viridien Board of Directors?

Helen LEE BOUYGUES has resigned from her position effective September 11, 2024.

Who is the new Director at Viridien?

Amélie OYARZABAL has been appointed as the new independent Director.

What is Amélie OYARZABAL’s professional background?

Amélie has over 25 years of experience in financial advisory, functioning in key roles at firms like Lazard and Greenhill & Co.

What committees will Amélie OYARZABAL be a part of?

Amélie will serve on the Audit & Risk Management Committee and the New Businesses and M&A Committee.

What is the stock ticker for Viridien?

Viridien is listed on the Euronext Paris SA under the ticker VIRI.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Major Refinancing Deal in Multifamily Sector by Newmark Group

Updated Category News Views 168

Newmark Group Secures $690 Million for West Shore Portfolio Newmark Group, Inc. (NASDAQ: NMRK), a prominent name in commercial real estate advisory, has successfully arranged a substantial $690 million loan aimed at refinancing a diverse collection of 13 multifamily properties owned by West Shore. These properties are located in several states, including vibrant areas...

Continue Reading
MassageLuXe Expands Its Relaxation Services in Grand Rapids

Updated Category News Views 193

MassageLuXe Expands Its Relaxation Services in Grand Rapids MassageLuXe, a leading spa franchise known for its exceptional massage, facial, and waxing services, is gearing up to enhance wellness offerings in the Grand Rapids area. This strategic initiative marks the company's intent to further establish its footprint in Michigan's second-largest city, driven by the...

Continue Reading
Taylor Heise Joins Upper Deck: A Milestone in Women's Sports

Updated Category News Views 454

Taylor Heise Joins Upper Deck's Elite Team of Athletes Leading the charge in the realm of sports collectibles, Upper Deck recently announced an exciting partnership with Taylor Heise, a standout player in the Professional Women's Hockey League (PWHL). This collaboration highlights the growing prominence of women athletes in sports collectibles, specifically with Heise,...

Continue Reading
Eminent Gold Strengthens Team with Ivan Bebek's Expertise

Updated Category News Views 81

Eminent Gold Welcomes Ivan Bebek as Strategic Advisor Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) is making headlines with the recent appointment of Ivan Bebek as a Strategic Advisor for Corporate Development and Finance. This strategic move aims to bolster the company's efforts in identifying and advancing new gold discoveries in Nevada. Ivan Bebek: A Wealth of...

Continue Reading
B. Riley Financial Plans Hearing for Nasdaq Compliance Status

Updated Category News Views 167

Understanding B. Riley Financial's Nasdaq Situation B. Riley Financial, Inc. (Nasdaq: RILY) has announced a significant event regarding its listing status on the Nasdaq exchange. The company received a Staff Determination Letter from the Nasdaq Listing Qualifications Staff, pointing out non-compliance issues that date back to earlier notifications. These notifications...

Continue Reading